PAREXEL's ParXware Integtrates with Spotfire.net

PAREXEL International Corporation and Spotfire Inc announced that they will demonstrate integration of PAREXEL's Web-based, data warehousing offering, ParXware, and Spotfire's decision analytics platform, Spotfire.net, to provide a comprehensive clinical trial data analysis solution that they will preview at the 36th Annual Drug Information Association (DIA) Meeting in San Diego, California.

Specifically, PAREXEL will demonstrate the benefits of integrating various clinical trial data - including associated medical images - in ParXware with the Spotfire.net analytics platform. Within the multi-dimensional, interactive environment of Spotfire.net, users can quickly and easily access large amounts of disparate data from ParXware and analyze the data to make visual comparisons, view trends and anomalies, and draw conclusions quickly. Data from electronic lab test results, EKGs and MRIs can also be delivered from ParXware for analysis in Spotfire.net. In addition to the powerful analytical capabilities of this integrated clinical trial solution, users can also benefit from its enterprise-wide capabilities to access, analyze and publish data within a collaborative, connected technical community.

"We are excited about the opportunity to preview a uniquely integrated clinical trial analysis solution that supports in-depth, open exploration," said Mark A. Goldberg, M.D., senior vice president of PAREXEL's Advanced Technology and Informatics Business Unit. "The data warehousing capabilities of ParXware, combined with the integrated decision analytics platform of Spotfire.net, will illustrate how customers can make faster, more informed decisions."

"We are very pleased to be working with PAREXEL, one of the largest contract research organization in the world, as we expand the application of our decision support tools into the clinical development arena," said Joseph F. Donahue, Spotfire vice president, Worldwide Life Sciences Market. "This integration gives users the means to rapidly access, analyze and publish data from increasingly disparate data sources in order to accelerate the discovery of life-saving drugs."

Spotfire Inc is a premier provider of decision analytics - speeding the discovery, development, manufacture, and marketing of products across the extended enterprise. Spotfire's solutions enable scientists, engineers, and product managers to improve the efficiency, speed and accuracy of their decision-making processes by advancing both individual and collaborative analysis and decision-making. Spotfire's offerings are currently in use at each of the top 25 pharmaceutical companies worldwide as well as major biotech, agrichemical, chemical, and manufacturing companies. The company maintains European headquarters in Goteborg, Sweden and U.S. headquarters in Cambridge, Mass. Additional information can be found at www.spotfire.com.

PAREXEL is one of the largest contract pharmaceutical outsourcing organizations in the world, providing a broad range of knowledge-based contract research, medical marketing and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. With a commitment to providing solutions that accelerate time-to-market and peak market penetration, PAREXEL has developed significant expertise in clinical trials management, data management, biostatistical analysis, medical marketing, clinical pharmacology, regulatory and medical consulting, industry training and publishing and other drug development consulting services. The Company's integrated services, therapeutic area depth and sophisticated information technology, along with its experience in global drug development and product launch services, represent key competitive strengths. Headquartered near Boston, MA, PAREXEL operates in 43 locations throughout 29 countries around the world, and has approximately 4,275 employees. Web site: www.PAREXEL.com.

Contact Kate McCorriston of PAREXEL International Corporation, 610-565-2622 x2630, kate.mccorriston@parexel.com or Mike Akillian of Spotfire Inc, 617-621- 0340 x111, mike.akillian@spotfire.com.